HeyJaredAshley K. Justice
- Indexed articles, last 90 days
- 2
- Latest publication
- Sep 10, 2026
- Outlet visibility, for natlawreview.com
- Top 1M sites
- Earliest in this view
- Jul 30, 2026
Latest articles
Chemical Structure, Formula, and Name Support Written Description of Pharmaceutical Genus (opens the original)
Read excerpt
The US Court of Appeals for the Federal Circuit affirmed that a patent’s specification provided adequate written description support for genus claims directed to crystalline cabozantinib (L)-malate salts because it disclosed structural features common to the claimed genus. Exelixis, Inc. v. MSN Laboratories Private Ltd., Case No. 25-1236 (Fed. Cir. Aug. 31, 2026) (Stoll, J.; Moore, C.J.; Moore, District J., sitting by designation). Exelixis holds the New Drug Application for Cabometyx®, a cancer
Book of Wisdom Has Limits: Can’t Impute Knowledge of Later-Arising Facts to Hypothetical Negotiation (opens the original)
Read excerpt
The US Court of Appeals for the Federal Circuit vacated in part a US Court of Federal Claims damages award, finding that the court erred in applying the book of wisdom in its damages analysis and assessing noncompensatory damages against the government. 4DD Holdings, LLC, et al. v. United States, Case No. 2024-1996 (Fed. Cir. July 16, 2026) (Hughes, Prost, Stark, JJ.) 4DD licensed TETRA software to the US Department of Defense and the US Department of Veterans Affairs to improve interoperability
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 1M sites
For natlawreview.com, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.